中医辨证联合标准集束化治疗对脓毒性休克患者的影响
该前瞻性随机对照试验纳入2016年1月1日至2017年12月31日上海交通大学医学院附属瑞金医院重症医学科收治的50例急性虚证脓毒性休克患者,随机分为对照组和参附组各25例,两组均早期应用标准集束化治疗,参附组额外给予参附注射液60 mL静脉输注7天。结果显示参附组中医症状评分显效率显著高于对照组,平均动脉压升高幅度、乳酸和降钙素原下降幅度、活化部分凝血活酶时间缩短幅度及白细胞介素-2受体和白细胞介素-6下降幅度均显著优于对照组,但血管活性药物使用时间、机械通气时间、疾病严重程度和28天死亡率两组无显著差异。作者认为中医证候评分有助于评价辨证论治效果,辨证论治联合标准集束化治疗可显著改善脓毒性休克患者的循环、组织灌注、凝血功能和炎症反应。
要点
- 参附组中医症状评分显效率60.0%(15/25)显著高于对照组16.0%(4/25),P<0.01。
- 参附组平均动脉压升高幅度13.0(2.5,28.5)mmHg显著大于对照组6.0(0,13.5)mmHg。
- 参附组乳酸下降0.8(0.1,3.7)mmol/L、降钙素原下降2.0(0.7,32.3)μg/L,均显著大于对照组。
- 参附组活化部分凝血活酶时间缩短8.5(0,12.9)s显著大于对照组0(-7.2,10.0)s。
- 两组血管活性药物使用时间、机械通气时间、疾病严重程度及28天死亡率无显著差异。
适用人群与场景
- 2016年1月1日至2017年12月31日上海交通大学医学院附属瑞金医院重症医学科收治的急性虚证脓毒性休克患者。
- 最终纳入分析50例,对照组25例、参附组25例。
处置流程与药物剂量
- 两组均早期应用标准集束化治疗。
- 参附组在标准集束化治疗基础上额外给予参附注射液60 mL静脉输注,疗程7天。
- 采用中医症状分类与评分法评估中医证候评分。
研究设计与关键结果
- 研究类型为前瞻性随机对照试验,纳入50例急性虚证脓毒性休克患者,对照组25例、参附组25例。
- 参附组中医症状评分显效率60.0%(15/25)显著高于对照组16.0%(4/25),P<0.01。
- 治疗后参附组平均动脉压升高幅度13.0(2.5,28.5)mmHg显著大于对照组6.0(0,13.5)mmHg。
- 参附组乳酸下降幅度0.8(0.1,3.7)mmol/L显著大于对照组0.5(-0.6,1.7)mmol/L;降钙素原下降幅度2.0(0.7,32.3)μg/L显著大于对照组0(-1.8,3.8)μg/L。
- 参附组活化部分凝血活酶时间缩短8.5(0,12.9)s显著大于对照组0(-7.2,10.0)s。
- 参附组白细胞介素-2受体下降1 031.0(533.0,1 840.0)ng/L显著大于对照组525.5(186.0,1 166.8)ng/L;白细胞介素-6下降153.1(21.4,406.8)ng/L显著大于对照组35.1(16.3,110.1)ng/L,均P<0.05。
- 两组血管活性药物使用时间、机械通气时间、疾病严重程度及28天死亡率无显著差异;参附组血管活性药物使用时间5.48±4.81天短于对照组8.28±7.83天,28天死亡率8.0%(2/25)低于对照组20.0%(5/25)。
证据类型、等级与局限
- 证据类型为前瞻性随机对照试验(RCT)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为中医证候评分有助于评价辨证论治效果,临床应用有效可行。
- 作者认为脓毒性休克患者采用中医辨证论治联合标准集束化治疗可显著改善循环、组织灌注、凝血功能和炎症反应。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate an effective and feasible quantitative evaluation table of traditional Chinese medicine (TCM) syndrome differentiation, and to observe the effect of combination of TCM syndrome differentiation and standard bundle therapy in patients with septic shock.
METHODS: A prospective randomized controlled trial was conducted. The septic shock patients with acute deficiency syndrome admitted to department of critical care medicine of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine from January 1st, 2016 to December 31st, 2017 were enrolled. The patients were randomly divided into control group and Shenfu group. The patients in both groups received early application of standardized bundle therapy; those in Shenfu group received 60 mL Shenfu injection infusion in addition for 7 days. The TCM syndrome score was evaluated by classification and scoring method of TCM symptoms. The circulation and tissue perfusion, severity of disease, organ function, inflammation response, adjuvant treatment and 28-day mortality were compared between the two groups.
RESULTS: A total of 50 patients with septic shock were enrolled in the analysis, 25 in control group and 25 in Shenfu group. The markedly effective rate of TCM symptoms score in Shenfu group was significantly higher than that in control group [60.0% (15/25) vs. 16.0% (4/25), P < 0.01]. There was no significant difference in all parameters before treatment between the two groups. After treatment, the observation indexes of both groups were improved. Compared with control group, the mean arterial pressure (MAP) in Shenfu group increased more significantly [mmHg (1 mmHg = 0.133 kPa): 13.0 (2.5, 28.5) vs. 6.0 (0, 13.5)], the lactate (Lac) and procalcitonin (PCT) decreased more significantly [Lac (mmol/L): 0.8 (0.1, 3.7) vs. 0.5 (-0.6, 1.7), PCT (μg/L): 2.0 (0.7, 32.3) vs. 0 (-1.8, 3.8)], activated partial thromboplastin time (APTT) was shortened more significantly [s: 8.5 (0, 12.9) vs. 0 (-7.2, 10.0)], and interleukins (IL-2 receptor and IL-6) levels decreased more significantly [IL-2 receptor (ng/L): 1 031.0 (533.0, 1 840.0) vs. 525.5 (186.0, 1 166.8), IL-6 (ng/L): 153.1 (21.4, 406.8) vs. 35.1 (16.3, 110.1)] with significant differences (all P < 0.05). There was no significant difference in the use time of vasoactive drugs, duration of mechanical ventilation, severity of the disease or 28-day mortality between the two groups. However, the use time of vasoactive drugs in Shenfu group was shorter than that in control group (days: 5.48±4.81 vs. 8.28±7.83), and the 28-day mortality was decreased [8.0% (2/25) vs. 20.0% (5/25)].
CONCLUSIONS: TCM syndrome score is helpful to evaluate the effect of TCM syndrome differentiation and treatment, and it is effective and feasible in clinical application. Septic shock patients treated with TCM syndrome differentiation and treatment combined with standard bundle therapy were significantly improved in circulation, tissue perfusion, coagulation function and inflammation reaction.
参考来源
- Li M, Pan T, Lyu L, et al. [Effect of traditional Chinese medicine syndrome differentiation and standard bundle therapy in patients with septic shock]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31441409. doi:10.3760/cma.j.issn.2095-4352.2019.07.011
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。